All Stories

  1. Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis

    Article • British Journal of Hospital Medicine, August 2018, Mark Allen Group

    Roger Chapman

  2. Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?

    Article • Alimentary Pharmacology & Therapeutics, April 2018, Wiley

    Roger Chapman

  3. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

    Article • Hepatology, January 2018, Wiley

    Roger Chapman, Professor Albert Pares

  4. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study

    Article • Hepatology, January 2017, Wiley

    Roger Chapman

  5. New Therapeutic Strategies for Primary Sclerosing Cholangitis

    Article • Seminars in Liver Disease, February 2016, Thieme Publishing Group

    Roger Chapman

  6. Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC

    Article • Alimentary Pharmacology & Therapeutics, December 2014, Wiley

    Roger Chapman